Background New drugs and new evidence concerning the use of established treatments
have become available since the publication of the first European League Against …

Abstract Objective To develop French Society of Rheumatology-endorsed recommendations
for the management of urate-lowering therapy (ULT). Methods Evidence-based …

Background 1–2% of adults in Germany suffer from gout. Gout is one of the few
rheumatological diseases that can be cured. It arises through the deposition of uric acid …

Objective: To develop evidence based recommendations for the management of gout.
Methods: The multidisciplinary guideline development group comprised 19 rheumatologists …

Objective To provide guidance for the management of gout, including indications for and
optimal use of urate‐lowering therapy (ULT), treatment of gout flares, and lifestyle and other …

Objectives. To determine if urate-lowering treatment (ULT) in gout can reduce
cardiovascular (CV) outcomes. Methods. Randomized trials were searched for treatment …

Gout, a disease recognized since antiquity, has increased in prevalence in recent years and
the clinical profile of this disease has become increasingly complex, owing to large numbers …

We aimed to develop evidence-based multinational recommendations for the diagnosis and
management of gout. Using a formal voting process, a panel of 78 international …

Background Gout is the most prevalent inflammatory arthritis in the Asia‐Pacific region and
worldwide. This clinical practice guideline (CPG) aims to provide recommendations based …

Gout is the most common cause of inflammatory arthritis worldwide. In UK general practice,
the overall prevalence has increased from 1.4% in 1999 to 2.49% in 2012 [1], despite the …